ResearchGuide Logo

Research Support Chat

Author

Advanced search ?

Discover the optimal journal based on multiple criteria or locate authors along with their published articles and the corresponding journals.

Publisher

* You can search a publisher or tap the name directly

Subject Area

* You can search a subject area or tap the name directly

Open Acess

Quartille





Publication Year

Comments on “Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics”

Authors : deniz can guven
Volume : 154
Pages : 585-585
2023

A Snapshot of Oral Microbiota in Patients with Colorectal Cancer

Authors : deniz can guven
2021

Looking at FOxTROT Through the Lens of IDEA

Authors : deniz can guven
Volume : 41
Pages : 4821-4822
2023

Higher Systemic Immune-Inflammation Index (SII) Levels Are Associated With Poorer Survival In Immunotherapy-Treated Melanoma Patients

Authors : deniz can guven
2021

Reassurance of patients with cancer on cancer care continuum: a vital strategy to prevent anxiety of COVID-19 collateral damage

Authors : deniz can guven
Volume : 29
Pages : 3423-3424
2021

Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms

Authors : deniz can guven , suayib yalcin
Volume : 51
Pages : 1365-1366
2021

Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis

Authors : taha koray sahin , deniz can guven
Volume : 63
Pages : 829-836
2024

The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis

Authors : deniz can guven , taha koray sahin
Volume : 204
Pages : 443-452
2024

A novel agnostic tumor: NTRKoma

Authors : ruveyda ayasun , deniz can guven , ibrahim gullu
Volume : 27
Pages : 802-803
2021

Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report

Authors : hakan taban , deniz can guven , saadettin kılıçkap
2022

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

Authors : deniz can guven , taha koray sahin , sercan aksoy
Volume : 27
Pages : 104-104
2020

The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer

Authors : deniz can guven , taha koray sahin , saadettin kilickap
Volume : 16
Pages : 156
2023

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

Authors : deniz can guven , taha koray sahin , sercan aksoy
Volume : 26
Pages : 2435-2436
2020

Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis

Authors : onur bas , enes erul , deniz can guven , sercan aksoy
Volume : 30
Pages : 9071-9078
2022

Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature Review

Authors : ecem yigit , deniz can guven , sercan aksoy , gozde yazici
2021

Editorial: Advances in the treatment of hormonal receptor positive (HR+) breast cancer

Authors : wala ben kridis , zheng wang , deniz can guven , arunasalam dharmarajan
Volume : 14
2024

Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications

Authors : deniz can guven , burak yasin aktas , cem simsek , sercan aksoy
Volume : 16
Pages : 497-506
2020

Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis

Authors : taha koray sahin , alessandro rizzo , sercan aksoy , deniz can guven
Volume : 16
Pages : 1835
2024